BioCryst Pharmaceuticals(BCRX)
DURHAM, NCPharmaceutical
Focus: BioCryst is a small-molecule pharmaceutical company headquartered in Durham, NC, focused on rare diseases in neurology and infectious diseases. The company is publicly traded (BCRX) with a heavily concentrated revenue base from its lead product ORLADEYO.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
23+5 this month
Growing — net +5 jobs in 30d
10 jobs added vs 5 removed. Steady team buildout.
Should You Work at BioCryst Pharmaceuticals?
AI assessmentBioCryst offers high-impact rare disease work with a stable lead product, but the single-revenue-stream model and cash burn create material career risk; best suited for R&D scientists seeking pipeline exposure with tolerance for restructuring scenarios.
Why Work Here
- Work on ORLADEYO (berotralstat), a peak-cycle product generating $52M in Part D spending with LOE protection until 2040, offering stability and clinical impact in hereditary angioedema treatment.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
1 imminent
RAPIVAB
Hiring
Stable
Revenue
$331M
FY2025
Key Products
$52M (Part D)Growing
Peak
Help build intelligence for BioCryst Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.